Characteristics of patients in the study
| . | 24-hour purge (n = 20) . | 72-hour purge (n = 5) . |
|---|---|---|
| Total, no. (%) | 18 (90) | 2 (40) |
| 2 (10) | 3 (60) | |
| Age, y | ||
| Mean | 44.6 | 50.8 |
| SD | 8.0 | 7.9 |
| Minimum | 31.0 | 37.0 |
| Maximum | 59.0 | 57.0 |
| Gender, no. (%) | ||
| Males | 11 (55) | 1 (20) |
| Females | 9 (45) | 4 (80) |
| Prior therapy, no. (%) | ||
| Hydrea | 20 (100) | 5 (100) |
| IFN | 16 (80) | 4 (80) |
| Busulfan | 0 (0) | 1 (20) |
| Ida/Ara-C | 1 (6) | 1 (20) |
| ICE | 0 (0) | 1 (20) |
| Time since diagnosis, y | ||
| Mean | 3.1 | 2.2 |
| SD | 2.9 | 1.1 |
| Minimum | 0.6 | 1.0 |
| Maximum | 13.2 | 3.6 |
| . | 24-hour purge (n = 20) . | 72-hour purge (n = 5) . |
|---|---|---|
| Total, no. (%) | 18 (90) | 2 (40) |
| 2 (10) | 3 (60) | |
| Age, y | ||
| Mean | 44.6 | 50.8 |
| SD | 8.0 | 7.9 |
| Minimum | 31.0 | 37.0 |
| Maximum | 59.0 | 57.0 |
| Gender, no. (%) | ||
| Males | 11 (55) | 1 (20) |
| Females | 9 (45) | 4 (80) |
| Prior therapy, no. (%) | ||
| Hydrea | 20 (100) | 5 (100) |
| IFN | 16 (80) | 4 (80) |
| Busulfan | 0 (0) | 1 (20) |
| Ida/Ara-C | 1 (6) | 1 (20) |
| ICE | 0 (0) | 1 (20) |
| Time since diagnosis, y | ||
| Mean | 3.1 | 2.2 |
| SD | 2.9 | 1.1 |
| Minimum | 0.6 | 1.0 |
| Maximum | 13.2 | 3.6 |
IFN indicates interferon; ICE, ifosfamide, carboplatin, and etoposide.